Literature DB >> 21351812

The 26th International Pediatric Association Congress of Pediatrics, Johannesburg, South Africa, 4-9 August 2010.

Michelle I Wilde1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21351812     DOI: 10.2165/11532630-000000000-00000

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  12 in total

Review 1.  Global epidemiology of meningococcal disease.

Authors:  Lee H Harrison; Caroline L Trotter; Mary E Ramsay
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

Review 2.  Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].

Authors:  Sean T Duggan
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

Review 3.  Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.

Authors:  Paul L McCormack; Elmar A Joura
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 4.  Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

Review 5.  Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults.

Authors:  Emma D Deeks
Journal:  BioDrugs       Date:  2010-10-01       Impact factor: 5.807

Review 6.  Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.

Authors:  Malcolm J M Darkes; Greg L Plosker
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children.

Authors:  M Knuf; D Kieninger-Baum; P Habermehl; P Muttonen; H Maurer; P Vink; J Poolman; D Boutriau
Journal:  Vaccine       Date:  2009-11-01       Impact factor: 3.641

Review 8.  Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis.

Authors:  Paul L McCormack; Susan J Keam
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 9.  Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Authors:  Jamie D Croxtall; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

10.  Rotavirus and severe childhood diarrhea.

Authors:  Umesh D Parashar; Christopher J Gibson; Joseph S Bresee; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.